DEBN Competitors and Similar CompaniesClear all
DEBN's competitors and similar companies include nRichDX, MDxHealth, Nucleix and Precipio.
 nRichDX nRichDX is a biotech company providing liquid biopsy sample preparation for molecular testing. |  MDxHealth MDxHealth is a molecular diagnostics company that develops and commercializes tests for cancer and other urologic diseases diagnosis. |  Nucleix Nucleix is a company that develops, manufactures, and markets non-invasive molecular cancer diagnostic tests. |  Precipio Precipio (formerly Transgenomic) is a company operating as a cancer diagnostics reference laboratory providing products and services to the oncology market. | ||
Founding Date | Founding Date 2017 | Founding Date N/A | Founding Date 2003 | Founding Date 2008 | Founding Date 1997 |
Type | Type Private | Type Private | Type Public | Type Private | Type Public |
Tags | |||||
Locations | Locations Gdańsk, PL HQ Renens, CH | Locations Irvine, US HQ | Locations Herstal, BE HQ Nijmegen, NL Irvine, US Plano, US | Locations Rehovot, IL HQ San Diego, US | Locations Omaha, US HQ Glasgow, GB New Haven, US Omaha, US |
Employees | Employees 3 | Employees 18 | Employees 252 | Employees 72 | Employees 4235% increase |
Valuation ($) | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 93.5 m | Valuation ($) N/A | Valuation ($) 9.3 m |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) $107.9m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) $24m (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods N/A | Cost of goods $36.1m (FY, 2025) | Cost of goods N/A | Cost of goods $13.3m (FY, 2025) |
Gross profit | Gross profit N/A | Gross profit N/A | Gross profit $71.8m (FY, 2025) | Gross profit N/A | Gross profit $10.7m (FY, 2025) |
Net income | Net income N/A | Net income N/A | Net income ($33.5m) (FY, 2025) | Net income N/A | Net income ($363k) (FY, 2025) |
Funding | |||||
Total funding raised | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 1.1m | Total funding raised $ 61m | Total funding raised $ 1.5m |
For sources of this data, please see the company profile
View Company Profiles
nRichDX
HQ
Irvine, US
Employees
18
nRichDX is a biotech company providing liquid biopsy sample preparation for molecular testing.
View companyMDxHealth
HQ
Herstal, BE
Employees
252
MDxHealth is a molecular diagnostics company that develops and commercializes tests for cancer and other urologic diseases diagnosis.
View companyNucleix
HQ
Rehovot, IL
Employees
72
Nucleix is a company that develops, manufactures, and markets non-invasive molecular cancer diagnostic tests.
View companyPrecipio
HQ
Omaha, US
Employees
42↑ 35% increase
Precipio (formerly Transgenomic) is a company operating as a cancer diagnostics reference laboratory providing products and services to the oncology market.
View company